Developer docs
API playgroundTry for free, no card

Search company profiles

Anthony Nolan

Full company profile

uuid000dsqp

Namestring
Anthony Nolan
Legal namestring
Anthony Nolan
Company typeenum
Private
Founded yearint
1974
Descriptiontext

Anthony Nolan is a UK-registered non-profit charity founded in 1974 by Shirley Nolan following the death of her son Anthony, establishing the world's first register of volunteer bone marrow donors. The organisation operates a stem cell donor registry of over 920,000 potential donors aged 16-30, complemented by a Cord Blood Programme collecting umbilical cord blood at five UK hospitals, and the Anthony Nolan Research Institute (ANRI) which has advanced transplant science for 30 years. Core operations include donor recruitment through community channels (university Marrow groups, sports clubs, corporate partners, emergency services), HLA-typed donor matching for patients with blood cancers and disorders, and stem cell collection at NHS and private collection centres including a dedicated Nottingham facility opened in 2025.

The business model blends charitable funding with a growing commercial B2B layer. The primary revenue engine is voluntary income from individual donations (regular giving tiers from £3-£10/month, single gifts up to £40 per donor recruited), fundraising events, workplace and payroll giving, lottery, and raffles. A secondary revenue stream is fee-for-service Cell Therapy and Laboratory Services provided to pharmaceutical and biotech developers of autologous and allogeneic cell therapies, including umbilical cord tissue supplied under material transfer and license agreements to partners such as INmune Bio. Services are delivered to patients and donors free of charge; the Graft Identification Advisory Service (GIAS) supports NHS transplant centres in optimal donor selection. The customer base spans individual patients and families, registered donors, NHS transplant centres, and enterprise biotech clients, with concentration risk concentrated in the small commercial B2B segment while the donor-funded base is broadly diversified.

Short descriptiontext

Anthony Nolan is a UK non-profit charity operating the world's first stem cell donor registry, matching over 920,000 registered donors aged 16-30 with patients needing transplants, and providing cell therapy laboratory services to pharmaceutical and biotech developers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
stem cell registry, cord blood banking, cell therapy services, donor recruitment, transplant coordination
Industry4 codes
1Blood, Organ & Tissue Donation Organizations
CodeBPAGACAJPrimaryYes
2Cell & Tissue Banking (biobanking, cord blood/tissue)
CodeHLAAAGAEPrimaryNo
3Stem Cell Therapies (MSC/iPSC/HSC-derived)
CodeHLAAABAEPrimaryNo
4Blood Bank, Transfusion Medicine & Immunohematology
CodeHLAHAAAHPrimaryNo
NAICS code3 codes
  • Blood and Organ Banks621991
  • Voluntary Health Organizations813212
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Stem Cell Registry & Transplant Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Charitable Donations
TypeGrants Donations
Description

Individual donations, regular giving, and major gifts from supporters. Donors aged 31+ are encouraged to fund the recruitment of younger donors (aged 16-30).

anthonynolan.org
2Cell Therapy and Laboratory Services
TypeProfessional Services
Description

Fee-for-service laboratory and cell therapy services provided to pharmaceutical companies and biotech developers for cell therapy research and development.

anthonynolan.org
3Fundraising Events and Campaigns
TypeGrants Donations
Description

Revenue from challenge events (runs, cycles, skydives), lottery, Christmas raffle, workplace giving, and payroll giving schemes.

anthonynolan.org
4Umbilical Cord Tissue Provision
TypeLicensing Royalties
Description

Supply of umbilical cord tissue to biotech companies such as INmune Bio for cellular therapy development, governed by Material Transfer and License Agreements.

bioprocessintl.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Pricing details2 tiers
1Regular Gift monthly donation
ModelSubscriptionBilling cadenceMonthly
Notes

Regular giving options: £3/month helps fund swab kits for three potential donors, £5/month supports patients and families, £10/month helps make more transplants happen. Single gifts: £10 for swab kits for ten potential donors, £20 for research funding, £40 to recruit one new potential lifesaver to the register.

anthonynolan.org
2One-time donation
ModelOtherBilling cadencePay-as-you-go
Notes

£40 processes and adds a potential lifesaver to the stem cell register. Payroll giving allows pre-tax donations directly from gross salary, with tax relief at the donor's highest marginal rate.

anthonynolan.org
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Anthony Nolan operates the world's first stem cell donor register, recruiting and HLA-typing donors aged 16-30 to match with patients who need stem cell transplants for blood cancers and disorders. The charity also runs a Cord Blood Programme collecting and banking umbilical cord blood at five UK hospitals, and provides commercial Cell Therapy and Laboratory Services to pharmaceutical and biotech developers, alongside transplant-related patient support and research via the Anthony Nolan Research Institute (ANRI).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 84% of children diagnosed with cancer in the UK now survive for five years or more, yet two-thirds of survivors face risk of serious disabling or life-threatening conditions
+2 more records
Product overview1 text field

Anthony Nolan operates as a UK-based stem cell charity offering a portfolio of interconnected services centred on recruiting stem cell donors, maintaining a donor registry, and facilitating stem cell transplants. The core offering is the Stem Cell Register (containing over 920,000 potential donors), supplemented by the Cord Blood Programme for umbilical cord stem cell collection. The organisation provides Cell Therapy and Laboratory Services including the Nottingham Cell Collection Centre, and supports both autologous and allogeneic cell therapy developers through manufacturing collaborations. Anthony Nolan Research Institute (ANRI) drives scientific advancement in transplant outcomes. Patient-facing services include financial grants, a helpline, emotional support, and CAR T-cell therapy guidance. Volunteer programmes including Marrow (university students), Hero Project (youth education), and courier services enable community-based donor recruitment and logistics support.

Product and service8 records
1Anthony Nolan Stem Cell Register
CategoryCore Service / Donor Registry
Description

A database of over 920,000 potential stem cell donors aged 16-30 used to match donors with patients needing stem cell transplants for blood cancers and disorders. Recruits approximately 33,652 new donors per year and is searched by NHS transplant centres when looking for unrelated donors.

2Cord Blood Programme
CategoryCore Service / Cord Blood Banking
Description

Collects, processes and banks umbilical cord blood rich in stem cells for use in stem cell transplants. Operates cord blood collection sites at five UK hospitals, providing an additional source of stem cells for transplant patients.

3Cell Therapy and Laboratory Services
CategoryCore Service / Laboratory Services (B2B)
Description

Commercial fee-for-service laboratory services including stem cell processing, storage, distribution and donor material supply, delivered to pharmaceutical and biotech developers of both autologous and allogeneic cell therapies. Ethical sourcing with full traceability of donor materials from collection to patient release.

4Anthony Nolan Research Institute (ANRI)
CategoryResearch Service
Description

Anthony Nolan's in-house research institute focused on improving transplant outcomes and developing new treatments for blood cancers and disorders through scientific research. Allocates around £2.76 million per year to research activity.

5Patient Services
CategorySupport Service
Description

Comprehensive patient and family support including a helpline (0303 303 0303), telephone emotional support, clinical nurse specialists, and a Patients & Families Forum for peer support. Services are provided free of charge to transplant patients and their families.

6Anthony Nolan Grants
CategoryFinancial Support Service
Description

One-off financial grants provided to stem cell transplant and CAR T-cell therapy patients to help cover unexpected costs during and after treatment. Funded through charitable donations.

7Graft Identification Advisory Service (GIAS)
CategoryClinical Advisory Service
Description

Clinical service provided to UK transplant centres that uses expert analysis of donor-patient HLA compatibility to recommend the optimal unrelated donor match for each patient, supporting transplant planning and donor selection.

8CAR T-cell Therapy Support
CategoryPatient Information Service
Description

Information and support services for patients undergoing CAR T-cell therapy, including preparation guidance, treatment information, and recovery support resources. Complements the Patient Services offering for this specific therapy pathway.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-26
Description

Anthony Nolan and Great Ormond Street Hospital Charity announced a research partnership in June 2026 to study the long-term care and support needs of childhood cancer survivors, including psychological support, fertility preservation, and rehabilitation services. The partnership will conduct in-depth interviews with young survivors and their carers to develop evidence-backed recommendations for the NHS.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-29
Description

INmune Bio signed an amended Material Transfer and License Agreement with Anthony Nolan in April 2026 to secure umbilical cord tissue for its CORDStrom mesenchymal stromal cell platform. The expanded collaboration supports development of treatments for Recessive Dystrophic Epidermolysis Bullosa, solid tumors, osteoarthritis, and systemic lupus erythematosus. The partnership combines Anthony Nolan's 50 years of stem cell expertise with INmune Bio's CORDStrom platform.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-01
Description

Contract development and manufacturing organization eXmoor Pharma and Anthony Nolan Cell Therapy and Laboratory Services entered a collaboration in September 2025 to support developers of both autologous and allogeneic cell therapies. The partnership combines Anthony Nolan's donor registry and expertise in cell collection with eXmoor's integrated process development and manufacturing services, emphasizing ethical sourcing and complete traceability of donor materials from collection to patient release.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Anthony Nolan partners with NHS Blood and Transplant (NHSBT) on the Cord Support Programme and the Anthony Nolan and NHS Stem Cell Registry. When searching for a match, all UK registers are searched through the joint registry.

5African Caribbean Leukaemia Trust (ACLT)
Strategic tierCoreTypeGTM or Marketing Partner
Description

Anthony Nolan partners with the ACLT, an inspiring charity committed to giving hope to people with blood cancer in need of a stem cell transplant, particularly focusing on recruiting donors from Black, African, Caribbean, and mixed ethnic backgrounds.

anthonynolan.org
Strategic tierCoreTypeGTM or Marketing Partner
Description

GAA clubs across Ulster are recruiting hundreds of young people to the Anthony Nolan stem cell register, leveraging the association's community network to reach potential donors aged 16-30.

7Police Scotland
Strategic tierMajorTypeGTM or Marketing Partner
Description

Police Scotland and Anthony Nolan have been working in partnership for six years to recruit more potential lifesavers to the stem cell register, engaging police staff and their communities as donors.

anthonynolan.org
Strategic tierMajorTypeGTM or Marketing Partner
Description

Anthony Nolan and Scottish Fire & Rescue Service celebrate over 15 years of an award-winning and transformational partnership focused on recruiting fire service personnel and communities as stem cell donors.

9Next
Strategic tierMajorTypeGTM or Marketing Partner
Description

Next selected Anthony Nolan as Charity of the Year Partner for 2023 and 2024, engaging retail staff and customers in fundraising and donor recruitment activities.

anthonynolan.org
Strategic tierMajorTypeGTM or Marketing Partner
Description

RSM UK has helped facilitate over 7,741 lifesaving journeys all over the world through its partnership with Anthony Nolan, providing professional services support and fundraising.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Corporate partner engaged in fundraising activities to support Anthony Nolan's lifesaving work.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Construction industry corporate partner supporting Anthony Nolan through fundraising.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Leading law firm Chattertons selected Anthony Nolan as Charity of the Year Partner for 2025.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Dairy company Lactalis UK & Ireland is a past corporate partner of Anthony Nolan.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Transport for London partnership with Anthony Nolan for workplace engagement and donor recruitment among transport workers and commuters.

Strategic tierMinorTypeOthers
Description

Family Camp is facilitated by Over The Wall Camp and supported and part-funded by Anthony Nolan, providing camp experiences for families of children who have had transplants.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

German-founded global non-profit operating one of the world's largest stem cell donor registries with over 12 million registered donors. Closely comparable to Anthony Nolan in mission, donor-recruitment model, HLA typing infrastructure, and global registry partnerships.

TypeDirect peer
Description

US-based non-profit operating the largest marrow registry in the world, matching donors with patients for life-saving transplants. Directly comparable to Anthony Nolan in registry operations, cord blood services, and patient support offerings.

TypeBroad incumbent
Description

UK statutory body operating the British Bone Marrow Registry and cord blood banking alongside Anthony Nolan via the joint UK registry. Comparable as a peer UK registry operator with overlapping donor and transplant infrastructure.

TypeDirect peer
Description

US-based non-profit stem cell and bone marrow donor registry focused on recruiting donors from underrepresented ethnic backgrounds. Comparable to Anthony Nolan in mission, recruitment approach, and registry-based matching services.

5African Caribbean Leukaemia Trust (ACLT)
TypeDirect peer
Description

UK charity dedicated to recruiting stem cell donors from Black, African, Caribbean, and mixed ethnic backgrounds. Active partner of Anthony Nolan with directly overlapping donor recruitment mission and patient appeals.

6Sunflower Stem Cell Registry
TypeEmerging player
Description

Smaller donor registry that recruits stem cell donors and partners with other registries to facilitate matches. Comparable to Anthony Nolan in core donor-recruitment activity but at a meaningfully smaller scale.

TypeRegional player
Description

Operates Canada's OneMatch Stem Cell and Marrow Network, providing donor recruitment and matching services outside the UK. Comparable in registry operations and cord blood banking, but serves a different national geography.

TypeBroad incumbent
Description

Large US-based voluntary health organization funding blood cancer research, patient services, and advocacy. Comparable to Anthony Nolan as a major blood cancer non-profit, though with a broader advocacy and research funding remit rather than registry operations.

TypeEmerging player
Description

UK-based innovation centre accelerating cell and gene therapy development with laboratory, manufacturing, and clinical infrastructure. Comparable as a UK cell therapy ecosystem enabler intersecting with Anthony Nolan's Cell Therapy and Laboratory Services.

TypeEmerging player
Description

UK cell and gene therapy CDMO providing process development and manufacturing services. Active commercial partner of Anthony Nolan Cell Therapy and Laboratory Services, comparable in cell therapy laboratory services delivery.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Anthony Nolan

Stem Cell Registry & Transplant Servicesanthonynolan.org

Anthony Nolan is a UK non-profit charity operating the world's first stem cell donor registry, matching over 920,000 registered donors aged 16-30 with patients needing transplants, and providing cell therapy laboratory services to pharmaceutical and biotech developers.

What Anthony Nolan does

Anthony Nolan is a UK-registered non-profit charity founded in 1974 by Shirley Nolan following the death of her son Anthony, establishing the world's first register of volunteer bone marrow donors. The organisation operates a stem cell donor registry of over 920,000 potential donors aged 16-30, complemented by a Cord Blood Programme collecting umbilical cord blood at five UK hospitals, and the Anthony Nolan Research Institute (ANRI) which has advanced transplant science for 30 years. Core operations include donor recruitment through community channels (university Marrow groups, sports clubs, corporate partners, emergency services), HLA-typed donor matching for patients with blood cancers and disorders, and stem cell collection at NHS and private collection centres including a dedicated Nottingham facility opened in 2025.

The business model blends charitable funding with a growing commercial B2B layer. The primary revenue engine is voluntary income from individual donations (regular giving tiers from £3-£10/month, single gifts up to £40 per donor recruited), fundraising events, workplace and payroll giving, lottery, and raffles. A secondary revenue stream is fee-for-service Cell Therapy and Laboratory Services provided to pharmaceutical and biotech developers of autologous and allogeneic cell therapies, including umbilical cord tissue supplied under material transfer and license agreements to partners such as INmune Bio. Services are delivered to patients and donors free of charge; the Graft Identification Advisory Service (GIAS) supports NHS transplant centres in optimal donor selection. The customer base spans individual patients and families, registered donors, NHS transplant centres, and enterprise biotech clients, with concentration risk concentrated in the small commercial B2B segment while the donor-funded base is broadly diversified.

Anthony Nolan firmographics

Firmographics
Name
Anthony Nolan
Legal name
Anthony Nolan
Website
https://anthonynolan.org
Company type
Private
Founded year
1974
Operating status
Operating
Headcount range
251–500 employees
Short description
Anthony Nolan is a UK non-profit charity operating the world's first stem cell donor registry, matching over 920,000 registered donors aged 16-30 with patients needing transplants, and providing cell therapy laboratory services to pharmaceutical and biotech developers.
Ownership category
akta.pro rank

Anthony Nolan industry classification

Industry
Product category
Stem Cell Registry & Transplant Services
NAICS
Blood and Organ Banks (621991), Voluntary Health Organizations (813212), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro primary industry
Blood, Organ & Tissue Donation Organizations (BPAGACAJ)
akta.pro secondary industries
Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE), Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE), Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH)

Keywords

  • Stem cell registry
  • Cord blood banking
  • Cell therapy services
  • Donor recruitment
  • Transplant coordination

Where Anthony Nolan is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Anthony Nolan business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Charitable Donations: Individual donations, regular giving, and major gifts from supporters. Donors aged 31+ are encouraged to fund the recruitment of younger donors (aged 16-30).
  2. Cell Therapy and Laboratory Services: Fee-for-service laboratory and cell therapy services provided to pharmaceutical companies and biotech developers for cell therapy research and development.
  3. Fundraising Events and Campaigns: Revenue from challenge events (runs, cycles, skydives), lottery, Christmas raffle, workplace giving, and payroll giving schemes.
  4. Umbilical Cord Tissue Provision: Supply of umbilical cord tissue to biotech companies such as INmune Bio for cellular therapy development, governed by Material Transfer and License Agreements.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyRegular Gift monthly donation
OtherPay-as-you-goOne-time donation

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Anthony Nolan product offering

Product offering

Core offering

Anthony Nolan operates the world's first stem cell donor register, recruiting and HLA-typing donors aged 16-30 to match with patients who need stem cell transplants for blood cancers and disorders. The charity also runs a Cord Blood Programme collecting and banking umbilical cord blood at five UK hospitals, and provides commercial Cell Therapy and Laboratory Services to pharmaceutical and biotech developers, alongside transplant-related patient support and research via the Anthony Nolan Research Institute (ANRI).

Product overview

Anthony Nolan operates as a UK-based stem cell charity offering a portfolio of interconnected services centred on recruiting stem cell donors, maintaining a donor registry, and facilitating stem cell transplants. The core offering is the Stem Cell Register (containing over 920,000 potential donors), supplemented by the Cord Blood Programme for umbilical cord stem cell collection. The organisation provides Cell Therapy and Laboratory Services including the Nottingham Cell Collection Centre, and supports both autologous and allogeneic cell therapy developers through manufacturing collaborations. Anthony Nolan Research Institute (ANRI) drives scientific advancement in transplant outcomes. Patient-facing services include financial grants, a helpline, emotional support, and CAR T-cell therapy guidance. Volunteer programmes including Marrow (university students), Hero Project (youth education), and courier services enable community-based donor recruitment and logistics support.

Differentiator

Problem solved

Functional benefit

Products and services

  • Anthony Nolan Stem Cell Register A database of over 920,000 potential stem cell donors aged 16-30 used to match donors with patients needing stem cell transplants for blood cancers and disorders. Recruits approximately 33,652 new donors per year and is searched by NHS transplant centres when looking for unrelated donors.
  • Cord Blood Programme Collects, processes and banks umbilical cord blood rich in stem cells for use in stem cell transplants. Operates cord blood collection sites at five UK hospitals, providing an additional source of stem cells for transplant patients.
  • Cell Therapy and Laboratory Services Commercial fee-for-service laboratory services including stem cell processing, storage, distribution and donor material supply, delivered to pharmaceutical and biotech developers of both autologous and allogeneic cell therapies. Ethical sourcing with full traceability of donor materials from collection to patient release.
  • Anthony Nolan Research Institute (ANRI) Anthony Nolan's in-house research institute focused on improving transplant outcomes and developing new treatments for blood cancers and disorders through scientific research. Allocates around £2.76 million per year to research activity.
  • Patient Services Comprehensive patient and family support including a helpline (0303 303 0303), telephone emotional support, clinical nurse specialists, and a Patients & Families Forum for peer support. Services are provided free of charge to transplant patients and their families.
  • Anthony Nolan Grants One-off financial grants provided to stem cell transplant and CAR T-cell therapy patients to help cover unexpected costs during and after treatment. Funded through charitable donations.
  • Graft Identification Advisory Service (GIAS) Clinical service provided to UK transplant centres that uses expert analysis of donor-patient HLA compatibility to recommend the optimal unrelated donor match for each patient, supporting transplant planning and donor selection.
  • CAR T-cell Therapy Support Information and support services for patients undergoing CAR T-cell therapy, including preparation guidance, treatment information, and recovery support resources. Complements the Patient Services offering for this specific therapy pathway.

Quantifiable outcome

  • 84% of children diagnosed with cancer in the UK now survive for five years or more, yet two-thirds of survivors face risk of serious disabling or life-threatening conditions
  • +2 more outcomes

Companies that use Anthony Nolan

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Anthony Nolan technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Anthony Nolan partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered core, major and minor.

  • Great Ormond Street Hospital CharitycoreStrategic or Co-development Partner · 26 June 2026Anthony Nolan and Great Ormond Street Hospital Charity announced a research partnership in June 2026 to study the long-term care and support needs of childhood cancer survivors, including psychological support, fertility preservation, and rehabilitation services. The partnership will conduct in-depth interviews with young survivors and their carers to develop evidence-backed recommendations for the NHS.
  • INmune Bio Inc.coreStrategic or Co-development Partner · 29 April 2026INmune Bio signed an amended Material Transfer and License Agreement with Anthony Nolan in April 2026 to secure umbilical cord tissue for its CORDStrom mesenchymal stromal cell platform. The expanded collaboration supports development of treatments for Recessive Dystrophic Epidermolysis Bullosa, solid tumors, osteoarthritis, and systemic lupus erythematosus. The partnership combines Anthony Nolan's 50 years of stem cell expertise with INmune Bio's CORDStrom platform.
  • eXmoor PharmacoreStrategic or Co-development Partner · 1 September 2025Contract development and manufacturing organization eXmoor Pharma and Anthony Nolan Cell Therapy and Laboratory Services entered a collaboration in September 2025 to support developers of both autologous and allogeneic cell therapies. The partnership combines Anthony Nolan's donor registry and expertise in cell collection with eXmoor's integrated process development and manufacturing services, emphasizing ethical sourcing and complete traceability of donor materials from collection to patient release.
  • NHS Blood and TransplantcoreStrategic or Co-development PartnerAnthony Nolan partners with NHS Blood and Transplant (NHSBT) on the Cord Support Programme and the Anthony Nolan and NHS Stem Cell Registry. When searching for a match, all UK registers are searched through the joint registry.
  • African Caribbean Leukaemia Trust (ACLT)coreGTM or Marketing PartnerAnthony Nolan partners with the ACLT, an inspiring charity committed to giving hope to people with blood cancer in need of a stem cell transplant, particularly focusing on recruiting donors from Black, African, Caribbean, and mixed ethnic backgrounds.
  • Gaelic Athletic Association (GAA)coreGTM or Marketing PartnerGAA clubs across Ulster are recruiting hundreds of young people to the Anthony Nolan stem cell register, leveraging the association's community network to reach potential donors aged 16-30.
  • Police ScotlandmajorGTM or Marketing PartnerPolice Scotland and Anthony Nolan have been working in partnership for six years to recruit more potential lifesavers to the stem cell register, engaging police staff and their communities as donors.
  • Scottish Fire & Rescue Service (SFRS)majorGTM or Marketing PartnerAnthony Nolan and Scottish Fire & Rescue Service celebrate over 15 years of an award-winning and transformational partnership focused on recruiting fire service personnel and communities as stem cell donors.
  • NextmajorGTM or Marketing PartnerNext selected Anthony Nolan as Charity of the Year Partner for 2023 and 2024, engaging retail staff and customers in fundraising and donor recruitment activities.
  • RSM UKmajorGTM or Marketing PartnerRSM UK has helped facilitate over 7,741 lifesaving journeys all over the world through its partnership with Anthony Nolan, providing professional services support and fundraising.
  • Janus HendersonminorGTM or Marketing PartnerCorporate partner engaged in fundraising activities to support Anthony Nolan's lifesaving work.
  • TRAD UKminorGTM or Marketing PartnerConstruction industry corporate partner supporting Anthony Nolan through fundraising.
  • ChattertonsminorGTM or Marketing PartnerLeading law firm Chattertons selected Anthony Nolan as Charity of the Year Partner for 2025.
  • Lactalis UK & IrelandminorGTM or Marketing PartnerDairy company Lactalis UK & Ireland is a past corporate partner of Anthony Nolan.
  • Transport for LondonminorGTM or Marketing PartnerTransport for London partnership with Anthony Nolan for workplace engagement and donor recruitment among transport workers and commuters.
  • Over The Wall CampminorOthersFamily Camp is facilitated by Over The Wall Camp and supported and part-funded by Anthony Nolan, providing camp experiences for families of children who have had transplants.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Anthony Nolan competitors and assessment

Company assessment

Direct peers

  • DKMS: German-founded global non-profit operating one of the world's largest stem cell donor registries with over 12 million registered donors. Closely comparable to Anthony Nolan in mission, donor-recruitment model, HLA typing infrastructure, and global registry partnerships.
  • National Marrow Donor Program (Be The Match): US-based non-profit operating the largest marrow registry in the world, matching donors with patients for life-saving transplants. Directly comparable to Anthony Nolan in registry operations, cord blood services, and patient support offerings.
  • Gift of Life Marrow Registry: US-based non-profit stem cell and bone marrow donor registry focused on recruiting donors from underrepresented ethnic backgrounds. Comparable to Anthony Nolan in mission, recruitment approach, and registry-based matching services.
  • African Caribbean Leukaemia Trust (ACLT): UK charity dedicated to recruiting stem cell donors from Black, African, Caribbean, and mixed ethnic backgrounds. Active partner of Anthony Nolan with directly overlapping donor recruitment mission and patient appeals.

Broad incumbents

  • NHS Blood and Transplant (NHSBT): UK statutory body operating the British Bone Marrow Registry and cord blood banking alongside Anthony Nolan via the joint UK registry. Comparable as a peer UK registry operator with overlapping donor and transplant infrastructure.
  • Leukemia & Lymphoma Society: Large US-based voluntary health organization funding blood cancer research, patient services, and advocacy. Comparable to Anthony Nolan as a major blood cancer non-profit, though with a broader advocacy and research funding remit rather than registry operations.

Emerging players

  • Sunflower Stem Cell Registry: Smaller donor registry that recruits stem cell donors and partners with other registries to facilitate matches. Comparable to Anthony Nolan in core donor-recruitment activity but at a meaningfully smaller scale.
  • Cell and Gene Therapy Catapult: UK-based innovation centre accelerating cell and gene therapy development with laboratory, manufacturing, and clinical infrastructure. Comparable as a UK cell therapy ecosystem enabler intersecting with Anthony Nolan's Cell Therapy and Laboratory Services.
  • eXmoor Pharma: UK cell and gene therapy CDMO providing process development and manufacturing services. Active commercial partner of Anthony Nolan Cell Therapy and Laboratory Services, comparable in cell therapy laboratory services delivery.

Regional players

  • Canadian Blood Services Stem Cell Registry: Operates Canada's OneMatch Stem Cell and Marrow Network, providing donor recruitment and matching services outside the UK. Comparable in registry operations and cord blood banking, but serves a different national geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Anthony Nolan social profiles

Digital presence

Anthony Nolan financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Anthony Nolan leadership team

Management profile

Number of profiles

Anthony Nolan subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Anthony Nolan funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Anthony Nolan M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Anthony Nolan

What does Anthony Nolan do?

Anthony Nolan operates the world's first stem cell donor register, recruiting and HLA-typing donors aged 16-30 to match with patients who need stem cell transplants for blood cancers and disorders. The charity also runs a Cord Blood Programme collecting and banking umbilical cord blood at five UK hospitals, and provides commercial Cell Therapy and Laboratory Services to pharmaceutical and biotech developers, alongside transplant-related patient support and research via the Anthony Nolan Research Institute (ANRI).

Is Anthony Nolan a public or private company?

Anthony Nolan is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Anthony Nolan founded?

Anthony Nolan was founded in 1974. It employs 251 to 500 people.

Where is Anthony Nolan based?

Anthony Nolan is headquartered in London, United Kingdom, in the Europe region.

How does Anthony Nolan make money?

Four revenue lines are on record. Charitable Donations are the primary driver. The others are cell Therapy and Laboratory Services, fundraising Events and Campaigns and umbilical Cord Tissue Provision.

Who are Anthony Nolan's main competitors?

Direct peers on record are DKMS, National Marrow Donor Program (Be The Match), Gift of Life Marrow Registry and African Caribbean Leukaemia Trust (ACLT). Broad incumbents are NHS Blood and Transplant (NHSBT) and Leukemia & Lymphoma Society. Emerging players are Sunflower Stem Cell Registry, Cell and Gene Therapy Catapult and eXmoor Pharma. Canadian Blood Services Stem Cell Registry is listed as a regional player.

Does Anthony Nolan have an API?

No public API is recorded for Anthony Nolan.

What industry is Anthony Nolan in?

Anthony Nolan's product category is Stem Cell Registry & Transplant Services. Its primary akta.pro industry code is BPAGACAJ, Blood, Organ & Tissue Donation Organizations, with a secondary code of HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue). Its NAICS code is 621991 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Daily RecordBrave schoolgirl Ava takes on Kiltwalk to raise cash for transplant charity who saved her lifeAva Todd, a 13-year-old from Fife, walked 11 miles in Edinburgh's Kiltwalk to raise cash for Anthony Nolan, which saved her life with a stem cell transplant. The charity's 2016 campaign found her a donor, and she is due to celebrate her tenth transplant anniversary in December.Express.co.ukChildren who survive cancer shouldn't be forced to settle for survival aloneGreat Ormond Street Hospital Charity and Anthony Nolan have announced a partnership to conduct research into the long-term care and support needs of childhood cancer survivors, including psychological support, fertility preservation, and rehabilitation services. The article highlights that while 84% of children diagnosed with cancer in the UK now survive for five years or more, two-thirds of survivors face the risk of developing serious disabling or life-threatening conditions such as diabetes, heart conditions, and cognitive impairment. The organizations will conduct in-depth interviews with young survivors and their carers to develop evidence-backed recommendations for the NHS to implement.GlobeNewswireINmune Bio Inc. Announces First Quarter 2026 Results and Provides Business UpdateINmune Bio reported a Q1 2026 net loss of $5.4 million, down from $9.7 million a year earlier, and announced a pre-submission package for its CORDStrom platform with the UK MHRA. The company plans to file an MAA for CORDStrom in mid-summer, followed by EMA and FDA submissions, and expects a BLA in Q4 2026.Investing.comINmune Bio expands collaboration with Anthony Nolan charity By Investing.comINmune Bio Inc. has signed an amended Material Transfer and License Agreement with Anthony Nolan, a UK-based stem cell charity, to secure umbilical cord tissue for its CORDStrom mesenchymal stromal cell platform. The expanded collaboration, effective April 29, 2026, will support development of treatments for conditions including Recessive Dystrophic Epidermolysis Bullosa, solid tumors, osteoarthritis, and systemic lupus erythematosus. The company, which posted a Q4 2025 net loss of $45.9 million, separately presented preclinical data for its INB03 oncology candidate at the AACR Annual Meeting 2026.Stock TitanINmune Bio expands CORDStrom pact with Anthony NolanINmune Bio and Anthony Nolan announced an expanded collaboration on the CORDStrom™ MSC platform, effective April 29, 2026, to develop cellular therapies targeting Recessive Dystrophic Epidermolysis Bullosa (RDEB), oncology applications, and inflammatory diseases. The restated agreement secures long-term provision of umbilical cord tissue from Anthony Nolan’s procurement infrastructure to support INmune Bio's development of off-the-shelf cellular treatments for UK, EU, US, and global markets. The partnership combines Anthony Nolan’s 50 years of stem cell expertise with INmune Bio's CORDStrom platform to address manufacturing consistency challenges in mesenchymal stromal cell therapies.GlobeNewswireINmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory DiseasesINmune Bio and Anthony Nolan signed an amended agreement to expand CORDStrom™ platform collaboration, effective April 29, 2026. The partnership targets RDEB, oncology, and inflammatory diseases, using Anthony Nolan's umbilical cord tissue for standardized MSC banks. The company aims to deliver consistent, off-the-shelf cellular therapies for global markets.BioProcess InternationalEthical sourcing and manufacturing in cell therapyIn September, contract development and manufacturing organization eXmoor Pharma and cell-therapy service charity Anthony Nolan Cell Therapy and Laboratory Services entered a collaboration to support developers of both autologous and allogeneic cell therapies. The partnership combines Anthony Nolan's donor registry and expertise in cell collection with eXmoor's integrated process development and manufacturing services, emphasizing ethical sourcing and complete traceability of donor materials from collection to patient release. Industry experts note that while autologous treatments currently lead in commercialization and efficacy, allogeneic approaches show promising developments expected to yield clinical results in the coming years.North Devon GazetteDevon mum wins £4m luxury home – husband thought they’d won sausagesEmily Ward from Devon won a £4m luxury Cheshire home and £250,000 cash in an Omaze draw, with her husband initially thinking they'd won sausages. The draw raised £3.7m for Anthony Nolan's stem cell charity, and the couple plans to enjoy the house for family holidays.Manchester Evening NewsDream £4million home in Cheshire's Golden Triangle up for grabs for just £10Omaze is offering a £4 million four-bed home in Cheshire's Golden Triangle for a £10 entry, with the winner receiving £250,000 cash and mortgage-free ownership. The property includes an indoor pool and furnishings worth £165,000, and the draw raises funds for Anthony Nolan.PR NewswireBlood Cancer Charity, Anthony Nolan, Selects IGEL Endpoints to Boost Workplace Collaboration and Support Windows 10 MigrationAnthony Nolan, a UK-based blood cancer charity, has implemented IGEL UD3 desktop endpoints to support its organizational-wide Windows 10 migration and enhance multimedia collaboration for over 300 employees across its sites in London and Nottingham. The deployment, facilitated by reseller Metaphor IT and integrated with the charity's existing Citrix infrastructure and Microsoft Azure cloud services, was completed to enable video conferencing and improve workplace productivity. The charity stated that reliable, modern IT is essential to its mission of helping blood cancer patients find matching stem cell donors, with approximately 2,000 UK patients annually requiring donor searches.